Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis

OBJECTIVE: Use of tacrolimus in mild to moderate myasthenia gravis (MG) is generally limited to glucocorticoid‐refractory cases; the advantage of mono‐tacrolimus over mono‐glucocorticoids is unknown. METHODS: We included mild to moderate MG patients treated with mono‐tacrolimus (mono‐TAC) or mono‐gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhirong, Lei, Lin, Su, Shengyao, Zhang, Shu, Xie, Nairong, Li, Ling, Lu, Yan, Di, Li, Wang, Min, Xu, Min, Shen, Xin‐Ming, Da, Yuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109324/
https://www.ncbi.nlm.nih.gov/pubmed/36808840
http://dx.doi.org/10.1002/acn3.51746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109324/
https://www.ncbi.nlm.nih.gov/pubmed/36808840
http://dx.doi.org/10.1002/acn3.51746

Ejemplares similares